Routine retention awards with no departure or red flags — no trading signal. Monitor upcoming 10-Q for full award agreement details and any cash runway updates.
Price Chart
Executive Summary
ADC Therapeutics granted one-time retention awards to its CEO, CFO, and CMO totaling approximately $2.9M in cash and 1.09M RSUs, with a one-year vesting/clawback period. This is a routine retention mechanism for a small-cap biotech — no departures, no red flags, and no material financial impact beyond standard compensation.
Key Facts
- CEO Ameet Mallik received a $1,795,500 cash award and 675,000 RSUs
- CFO Jose Carmona received $541,842 cash and 203,700 RSUs
- CMO Mohamed Zaki received $568,974 cash and 213,900 RSUs
- Cash portion payable July 15, 2026; subject to clawback if employment terminates before June 30, 2027
- RSUs vest on June 30, 2027 or earlier upon termination without cause or for good reason
- No departures, resignations, or terminations disclosed
Financial Impact
One-time retention awards totaling approximately $2.9M in cash and 1.09M RSUs to three named executive officers
Risk Factors
- Cash awards (~$2.9M) increase near-term cash burn for a small-cap biotech
- RSU grants add ~1.09M shares of potential dilution over the next year
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0000950103-26-010195 |
| Document: 0000950103-26-010195-index-headers.html | 0000950103-26-010195 |
| Document: 0000950103-26-010195-index.html | 0000950103-26-010195 |
| Document: 0000950103-26-010195.txt | 0000950103-26-010195 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 13d ago | 8-K | $1.70 $1.52 | ▼ −10.59% | ▼ −9.44% | $1.51 (−11.18%) |
Aug 6, 2026 11w ago | Press Release | $1.13 $1.05 | ▼ −7.08% | ▼ −8.29% | $1.51 (+33.63%) |
Jul 2, 2026 16w ago | 8-K | $1.19 $1.30 | ▲ +9.24% | ▲ +8.31% | $1.51 (+26.89%) |
Jun 3, 2026 20w ago | 8-K | $1.32 $1.06 | ▼ −19.70% | ▼ −17.14% | $1.51 (+14.39%) |
May 4, 2026 25w ago | 8-K | $3.68 $3.48 | ▼ −5.43% | ▼ −8.37% | $1.51 (−58.97%) |
Apr 20, 2026 27w ago | DEFA14A | $4.25 $3.76 | ▼ −11.53% | ▼ −12.44% | $1.51 (−64.47%) |
Mar 17, 2026 32w ago | EFFECT | $4.11 $3.94 | ▼ −4.14% | ▼ −1.48% | $1.51 (−63.26%) |
Mar 10, 2026 32w ago | S-3 | $4.88 $4.01 | ▲ +17.83% | ▲ +15.64% | $1.51 (+69.06%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers